Nifty extended its winning streak, surpassing a key resistance level, but analysts foresee challenges around 25,500-25,670. Despite potential headwinds from US visa policy changes impacting the IT sector, technical indicators suggest a bullish outlook. Experts advise traders to capitalize on dips, highlighting Samman Capital and Piramal Pharma as potential buys with specific targets and stop-loss levels.
Is the smallcap rally a trap? Only 37% of stocks are outperforming their benchmark
India’s recent smallcap surge indicates that less stock is outpacing the benchmark index, revealing a narrowing group of successful stocks boosting overall returns. Conversely, largecap